Moderna, Inc. (FRA:0QF)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,930	15,455	34,305	64,569	90,547	33,795
Market Cap Growth	-78.61%	-54.95%	-46.87%	-28.69%	167.93%	481.82%
Enterprise Value	3,118	7,876	24,000	49,840	83,228	31,290
Last Close Price	22.79	38.33	89.41	166.06	219.00	96.00
PE Ratio	-	-	-	8.25	8.44	-
PS Ratio	3.41	4.95	5.54	3.58	5.58	51.48
PB Ratio	1.12	1.47	2.74	3.61	7.28	16.14
P/TBV Ratio	1.13	1.48	2.76	3.61	7.28	16.14
P/FCF Ratio	-	-	-	15.06	7.72	21.10
P/OCF Ratio	-	-	-	13.85	7.56	20.40
EV/Sales Ratio	1.18	2.52	3.87	2.77	5.12	47.67
EV/EBITDA Ratio	-	-	-	5.45	7.00	-
EV/EBIT Ratio	-	-	-	5.65	7.12	-
EV/FCF Ratio	-1.05	-	-	11.63	7.10	19.54
Debt / Equity Ratio	0.08	0.07	0.09	0.06	0.07	0.09
Debt / EBITDA Ratio	-	-	-	0.12	0.07	-
Debt / FCF Ratio	-	-	-	0.26	0.07	0.12
Asset Turnover	0.22	0.20	0.31	0.76	1.15	0.18
Inventory Turnover	16.52	37.66	13.92	6.02	5.19	-
Quick Ratio	3.56	3.45	3.21	2.35	1.54	1.37
Current Ratio	3.93	3.67	3.43	2.73	1.76	1.44
Return on Equity (ROE)	-27.50%	-28.77%	-28.59%	50.27%	146.08%	-39.99%
Return on Assets (ROA)	-14.77%	-15.14%	-11.96%	23.30%	51.93%	-10.68%
Return on Capital (ROIC)	-17.70%	-18.44%	-14.96%	33.28%	93.06%	-23.21%
Return on Capital Employed (ROCE)	-	-	-	45.00%	85.60%	-
Earnings Yield	-27.68%	-22.25%	-12.43%	12.12%	11.85%	-1.81%
FCF Yield	-33.28%	-25.34%	-10.09%	6.64%	12.95%	4.74%
Buyback Yield / Dilution	-1.05%	-0.52%	8.17%	3.48%	-13.12%	-15.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.